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Abstract
Background: Little empirical research has examined the multiple consequences of osteoporosis on
quality of life.
Methods: Health related quality of life (HRQL) was examined in relationship to incident fractures in 2009
postmenopausal women 50 years and older who were seen in consultation at our tertiary care, university
teaching hospital-affiliated office and who were registered in the Canadian Database of Osteoporosis and
Osteopenia (CANDOO) patients. Patients were divided into three study groups according to incident
fracture status: vertebral fractures, non-vertebral fractures and no fractures. Baseline assessments of
anthropometric data, medical history, therapeutic drug use, and prevalent fracture status were obtained
from all participants. The disease-targeted mini-Osteoporosis Quality of Life Questionnaire (mini-
OQLQ) was used to measure HRQL.
Results: Multiple regression analyses revealed that subjects who had experienced an incident vertebral
fracture had lower HRQL difference scores as compared with non-fractured participants in total score (-
0.86; 95% confidence intervals (CI): -1.30, -0.43) and the symptoms (-0.76; 95% CI: -1.23, -0.30), physical
functioning (-1.12; 95% CI: -1.57, -0.67), emotional functioning (-1.06; 95% CI: -1.44, -0.68), activities of
daily living (-1.47; 95% CI: -1.97, -0.96), and leisure (-0.92; 95% CI: -1.37, -0.47) domains of the mini-
OQLQ. Patients who experienced an incident non-vertebral fracture had lower HRQL difference scores
as compared with non-fractured participants in total score (-0.47; 95% CI: -0.70, -0.25), and the symptoms
(-0.25; 95% CI: -0.49, -0.01), physical functioning (-0.39; 95% CI: -0.65, -0.14), emotional functioning (-0.97;
95% CI: -1.20, -0.75) and the activities of daily living (-0.47; 95% CI: -0.73, -0.21) domains.
Conclusion: Quality of life decreased in patients who sustained incident vertebral and non-vertebral
fractures.
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Background
Osteoporosis, a skeletal disease characterized by low bone
mass and an increased risk of bone fragility fractures, is a
major health concern affecting a growing number of indi-
viduals worldwide [1,2]. Nearly 40% of Caucasian wom-
en age 50 years and older will experience at least one
fracture of the spine, hip, or wrist during their lives [3].
These fractures have physical, psychological and social
consequences that can profoundly affect health related
quality of life (HRQL). Patients with fractures may be un-
able to work, are limited in their social and recreational
activities, and are emotionally distressed [4–8]. As such,
women with fractures require extensive medical, and psy-
chological care and assistance with activities of daily liv-
ing.
Quality of life measures have gained increasing attention
as clinically relevant patient centered endpoints. Several
instruments, both generic and disease targeted, have been
created to examine health status [9–14]. However, most
instruments that evaluate quality of life have been prima-
rily developed for experimental trials. As a consequence,
these quality of life instruments are not easily incorporat-
ed into the real world of clinical practice since their length
and the long time needed to complete them limit their use
[15,16]. To enhance the usefulness of HRQL instruments
in clinical practice, shorter questionnaires must be devel-
oped. Our study is the first to measure the influence of in-
cident fractures on HRQL with a disease-targeted
instrument that was specifically created for clinical use.
Methods
Study Design
Data were obtained from the Canadian Database of Oste-
oporosis and Osteopenia (CANDOO) patients. CAN-
DOO consists of 8065 patients and involves 8 sites across
Canada (Calgary, n = 20; Saskatoon, n = 357; Winnipeg; n
= 4; Hamilton (2 sites), n = 6033; Montreal (2 sites), n =
1527; Quebec City, n = 124). This database is a prospec-
tive registry of patients designed to capture a comprehen-
sive set of osteoporosis-related clinical data during the
course of routine specialist care [17]. In particular, the
CANDOO contains electronically stored data regarding
basic patient demographics, fracture history, gynecologi-
cal history, past use of osteoporosis-related drug treat-
ment, drug side effects, past use of corticosteroids and
other medications, dietary calcium intake, smoking hab-
its, type and quantity of physical activities, fall history,
past medical history and family history including frac-
tures, a self administered osteoporosis HRQL instrument,
basic laboratory results, and bone density measurements.
One database record, with over 400 data fields per patient,
is generated for each patient at each clinical visit.
For the current analysis, the database was searched for
postmenopausal women 50 years of age and older who
were seen at one Hamilton site and who were registered in
CANDOO from 1994 to 1999. During this time period,
this location was the only CANDOO site that regularly ad-
ministered the osteoporosis HRQL instrument. At the
Hamilton site, all patients seen in the course of routine
specialist care were entered in CANDOO. On average pa-
tients were seen annually and the HRQL instrument was
administered at each clinical visit. Participants were
grouped according to incident fracture status. Group I: pa-
tients who experienced clinically recognized incident ver-
tebral fractures. Group II: patients who sustained incident
non-vertebral fractures. Incident fractures were registered
based on the patient's response to an item ("How many
new fractures have you had since your last visit?") from
the CANDOO questionnaire. Incident vertebral fractures
may or may not have been confirmed by x-ray. Incident
non-vertebral fractures included the ankle, arm, clavicle,
elbow, heel, hip, knee, leg, nose, pelvis, rib, shoulder, sac-
rum, and wrist. Group III: patients who did not report an
incident fracture.
Patients with incident fractures were eligible for study en-
try if they completed at least a portion of the HRQL ques-
tionnaire prior to (pre assessment) and following their
fracture (post assessment). Patients who did not report in-
cident fractures also had to complete the HRQL question-
naire twice. The duration between pre and post HRQL
measurements was matched between the three groups.
The mini-Osteoporosis Quality of Life Questionnaire
(mini-OQLQ) was used to measure HRQL. The instru-
ment is self-administered but is reviewed by the specialist
or a nurse clinician during each visit. The mini-OQLQ was
derived from the original 30 item Osteoporosis Quality of
Life Questionnaire (OQLQ) [18] to enhance the instru-
ment's usefulness in clinical practice. The mini-OQLQ in-
cludes the two items from the OQLQ with the highest
impact in each of the five domains (symptoms, physical
functioning, emotional functioning, activities of daily liv-
ing, and leisure), for a total of 10 items (Additional File).
Each item is associated with a seven-point scale. The total
score for the instrument can vary from 10 to 70, while the
domain scores can vary from 2 to 14. To standardized all
scores, the total and the domain scores were divided by
the number of items that were used to generate the values.
A standardized rating of 1 represents the worst possible
function (extreme difficulties, constant fear, extreme dis-
tress) and a rating of 7 represents the best possible func-
tion (no difficulties, no fear, no distress). It has been
suggested, from previous work, that changes within each
domain score of approximately 0.5 represents a clinically
important difference in quality of life [19,20]. The mini-
OQLQ instrument has been evaluated in osteoporoticBMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/11
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women with back pain due to vertebral fractures and has
been found to be reliable and valid both for measuring
differences in HRQL between patients with osteoporosis
and changes within these patients over time [21].
Statistical Analysis
Our primary objective was to determine the effect of ver-
tebral and non-vertebral fractures on HRQL. Multiple re-
gression analyses were performed to explain the
relationship between incident fractures and HRQL. From
these analyses, we determined regression coefficient esti-
mates (which represent differences between pre and post
HRQL measurements for both fractured and non-frac-
tured patients), as well as 95% confidence intervals (CI)
of the difference scores for the mini-OQLQ. The inde-
pendent variables entered in the models included group;
baseline mini-OQLQ score; group by baseline mini-
OQLQ score interaction; number of years between pre
and post administration of the mini-OQLQ; age; baseline
height; baseline weight; prevalent vertebral and non-ver-
tebral fracture status; number of prevalent vertebral and
non-vertebral fractures; time spent exercising; dietary cal-
cium intake; baseline bone mineral density of the lumbar
spine and femoral neck; medications such as bisphospho-
nates (etidronate or alendronate), estrogen, or others (cal-
citonin, fluoride or raloxifene); and co-morbidities
(including heart attack; stroke; breast, ovarian, cervical,
uterine and colon cancer, and multiple myeloma; diabe-
tes, epilepsy, arthritis, and thyroid disease). Regression
models were selected based on Mallows C(P) statistic. Sta-
tistical significance was defined as p<0.05. All analyses
were preformed on a Dell personal computer using a SAS/
STAT (version 7.0; SAS Institute Inc., Cary, NC, USA) soft-
ware package.
Results
Of the 5450 patients entered in CANDOO from the Ham-
ilton site, a total of 2009 postmenopausal women met the
inclusion criteria of the study. The majority of patients
were excluded because they were seen prior to 1994 (n =
1016), did not complete the mini-OQLQ twice (n =
2042), or were less than 50 years of age (n = 240). Among
the women examined, 47 sustained incident vertebral and
149 developed incident non-vertebral fractures. The re-
maining 1813 women did not experience an incident frac-
ture during the course of the study. The mean (standard
deviation) time between baseline and follow-up adminis-
tration of the mini-OQLQ for groups I, II and III was 1.2
(0.5), 1.2 (0.4), and 1.2 (0.4) years, respectively. The
mean (standard deviation) change in height between
baseline and follow-up assessment was -1.4 (1.9), -0.3
(1.2), and -0.2 (1.4) cm, for groups I, II and III respective-
ly. Table 1 presents patient characteristics for all three
groups.
Incident Fractures and HRQL
Vertebral Fractures
Since changes in HRQL were similar in patients with x-ray
confirmed vertebral fractures versus those with only re-
ported vertebral fractures (20 vs. 27 patients) based on the
CANDOO questionnaire (not confirmed by x-ray), all in-
cident vertebral fracture patients were grouped together.
Unadjusted HRQL standardized and difference scores
were lower in patients in group I as compared with those
in group III (Table 2 & 3). The difference scores between
groups remained statistically significant after the analysis
was adjusted for the other confounding variables for the
total and all five domains of the mini-OQLQ (Table 3).
Non-Vertebral Fractures
Unadjusted HRQL standardized and difference scores
were lower in patients in group II as compared with those
in group III (Table 2 & 3) in most domains of the mini-
OQLQ. After controlling for confounding variables, dif-
ferences persisted in the total score, and the symptoms,
physical functioning, emotional functioning and the ac-
tivities of daily living domains (Table 3).
Other Patient factors and HRQL
HRQL was negatively associated with increased age, ar-
thritis, and diabetes; whereas HRQL was positively associ-
ated with bisphosphonate use and the amount of time
spent exercising. However, while these patient factors
were associated with HRQL, the magnitude of the effects
across the domains of the mini-OQLQ were variable and
may or may not be clinically relevant (data not shown).
Discussion
The assessment of quality of life is needed to properly
quantify disease burden. While clinicians and investiga-
tors may utilize a variety of questionnaires to assess their
patients' HRQL, their length and the time they take to
complete may restrict their clinical usefulness. Short ques-
tionnaires minimize a patient's time and effort, and thus
increase a patient's willingness to complete the question-
naire. The Osteoporosis Quality of Life Study Group devel-
oped the mini-OQLQ to facilitate questionnaire
administration in clinical settings. The benefit of the
mini-OQLQ is that it is efficient, it is self administered,
and requires 2–3 minutes to complete. Data collected
from the mini-OQLQ, provide a unique opportunity to
determine the effect of incident fractures on HRQL in pa-
tients seen in ordinary clinical practice.
The physical, emotional and psychological disabilities,
and increased pain resulting from vertebral and non-ver-
tebral fractures are outcomes of osteoporosis that can ad-
versely influence HRQL. After adjusting for confounding
factors, our results show substantial impairment of quali-
ty of life in patients with incident vertebral fractures asBMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/11
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Table 1: Patient Characteristicsa
Incident VF Group (I) Incident Non-VF Group (II) No Incident Fracture Group (III)
Number of patients 47 149 1813
Age-mean (SD) 72.5 (8.6) 68.5 (9.6) 65.3 (8.8)
Weight-kg 62.2 (12.3) 64.9 (12.6) 64.8 (12.8)
Height – cm 154.4 (6.7) 156.9 (6.6) 157.4 (8.3)
Dietary Ca-g/d 0.8 (0.4) 0.6 (0.3) 0.6 (0.3)
Exercise-hours/week 1.8 (2.6) 2.8 (3.4) 2.9 (3.5)
Race-# (%)
Caucasian 10 (21.3) 29 (19.5) 473 (26.1)
Otherb 1 (2.1) 0 (0) 26 (1.4)
Unknown 36 (76.6) 120 (80.5) 1314 (72.5)
BMD-mean (SD)
LS-g/cm2 0.876 (0.131) 0.941 (0.169) 0.954 (0.148)
FN-g/cm2 0.687 (0.101) 0.715 (0.120) 0.734 (0.109)
Prevalent fractures – # (%)
VF 24 (51.1) 38 (25.5) 326 (18.0)
Non-VF 33 (70.2) 98 (66.8) 828 (45.7)
Multiple VF (>1) 16 (34.0) 17 (11.4) 194 (10.7)
Multiple Non-VF (>1) 22 (46.8) 59 (39.6) 467 (25.8)
Concomitant diseases-# (%)
Heart attack 7 (14.9) 25 (16.8) 262 (14.5)
Stroke 3 (6.4) 3 (2.0) 58 (3.2)
Cancerc 5 (10.6) 15 (10.0) 162 (8.9)
Diabetes 2 (4.3) 6 (4.0) 58 (3.2)
Epilepsy 2 (4.3) 2 (1.3) 17 (0.9)
Arthritis 25 (53.2) 78 (52.4) 1037 (57.2)
Thyroid diseased 13 (27.7) 36 (24.2) 345 (19.0)
Medications-# (%)
Bisphosphonatese 40 (85.1) 109 (73.2) 1252 (69.1)
Estrogen 16 (34.0) 50 (33.6) 767 (42.3)
Other medicationsf 4 (8.5) 3 (2.0) 42 (2.3)
a VF = vertebral fracture; Ca = calcium; SD = standard deviation; BMD = bone mineral density; LS = lumbar spine; FN = femoral neck; # = number 
of patients; % = percent of patients within each group. b others may have included one of the following Asian, Black, Aboriginal North American, 
Oriental, and Middle Eastern/North African White cincludes breast, ovarian, uterine or cervical, colon cancer; and multiple myeloma. d includes 
hyper, hypo, nodular and other thyroid diseases. e includes alendronate or etidronate. f includes fluoride, calcitonin or raloxifene.
Table 2: Unadjusted Standardized Scores of the mini-OQLQ for Patients With and Without Incident Fracturesa.
Mini-OQLQ Vertebral Fracture Group (I) Non-Vertebral Fracture Group (II) No Fracture Group (III)
Domains Baseline Follow-up n Baseline Follow-up n Baseline Follow-up n
Total Score 4.27 (1.83) 3.54 (1.79) 14 4.99 (1.37) 4.64 (1.35) 52 5.46 (1.43) 5.49 (1.36) 685
Symptoms 3.98 (1.76) 3.26 (1.65) 44 4.82 (1.62) 4.64 (1.51) 136 5.08 (1.61) 5.07 (1.62) 1711
Physical Functioning 3.99 (2.11) 3.26 (1.90) 34 5.14 (1.68) 4.83 (1.72) 102 5.26 (1.77) 5.31 (1.75) 1192
Emotional Function-
ing
4.16 (2.13) 3.72 (2.27) 45 5.41 (1.69) 4.54 (1.85) 139 5.65 (1.55) 5.67 (1.49) 1711
Activities of Daily 
Living
4.25 (2.12) 3.18 (1.91) 30 5.24 (1.80) 4.89 (1.84) 105 5.34 (1.81) 5.40 (1.75) 1260
Leisure 5.10 (2.07) 4.31 (2.20) 26 5.42 (1.84) 5.51 (1.78) 75 6.01 (1.54) 6.02 (1.51) 1012
a Only patients with both pre and post measurements were evaluated. Entries are means (standard deviation). n = sample size.BMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/11
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compared with those without fractures. This was evident
by the fact that HRQL was significantly lower in the total
score and all domains of the mini-OQLQ.
Due to the small number of non-vertebral fractures, differ-
ences between fracture types were not examined. The
mini-OQLQ was able to detect differences in HRQL be-
tween patients with incident non-vertebral and those
without fractures. Statistically significant changes were
seen in the total score and in the four domain scores of the
mini-OQLQ. Nonetheless, the clinical relevance of these
changes may be questioned. Based on these results, it is
tempting to conclude that vertebral fractures have a great-
er impact on HRQL as compared with non-vertebral frac-
tures. However, the mini-OQLQ was originally developed
to measure the affect of vertebral fractures on quality of
life and thus the instrument may be more responsive to
this fracture type. As a consequence, evaluating changes in
quality of life between vertebral and non-vertebral frac-
tures is not recommended.
It should be recognized that fractures are likely to be only
one of the many medical conditions that influence HRQL.
Osteoporotic fractures generally affect individuals' later in
life and a substantial proportion of these subjects may
have clinically relevant co-morbidities. In this study, qual-
ity of life was lower in patients who had either arthritis or
diabetes, exercised less, or did not use bisphosphonates.
While these results are clinically interesting, the findings
were based on secondary analyses and therefore they
should be interpreted with caution. Further research will
need to be conducted to determine the clinical impor-
tance of these patient factors on HRQL.
The strengths of this cohort study include the prospective
examination of both incident vertebral and non-vertebral
fractures. All participants in the study were "real world"
patients who were seen for osteoporosis in tertiary care
settings and thus represent a homogeneous group. Our
analysis adjusted for factors that may influence quality of
life such as co-morbidities, medications, activity levels
and baseline functional status. Furthermore, since the
mini-OQLQ is a disease-targeted instrument that meas-
ures characteristics relevant to osteoporosis, it may be
more sensitive in detecting differences between groups as
compared with generic HRQL instruments. Nonetheless,
our study is not without limitations. It is possible that oth-
er conditions such as abnormal spinal alignment, back
muscle weakness, or inflexibility may have contributed to
a reduced quality of life in these patients. Furthermore,
not all spinal fractures were confirmed by x-ray. X-rays
were performed only in patients with back pain. There-
Table 3: Unadjusted and Adjusted Regression Coefficient Estimates and 95% Confidence Intervals (CI) that Explain the mini-OQLQ for 
Patients With Incident Fractures Versus Those Without Incident Fracturesa.










Total Score -0.77 (699) -0.86 (673) -0.38 (737) -0.47 (711)
-1.22, -0.31 -1.30, -0.43 -0.62, -0.13 -0.70, -0.25
Symptoms -0.70 (1755) -0.76 (1214) -0.17 (1847) -0.25 (1295)
-1.12, -0.29 -1.23, -0.30 -0.41, 0.07c -0.49, -0.01
Physical Functioning -0.76 (1226) -1.12 (1113) -0.35 (1294) -0.39 (1181)
-1.20, -0.32 -1.57, -0.67 -0.62, -0.09 -0.65, -0.14
Emotional Functioning -0.46 (1756) -1.06 (1581) -0.90 (1850) -0.97 (1669)
-0.85, -0.07 -1.44, -0.68 -1.13, -0.66 -1.20, -0.75
Activities of Daily Living -1.13 (1290) -1.47 (1116) -0.41 (1365) -0.47 (1188)
-1.63, -0.63 -1.97, -0.96 -0.69, -0.14 -0.73, -0.21
Leisure -0.81 (1038) -0.92 (991) 0.08 (1087) -0.05 (953)
-1.29, -0.32 -1.37, -0.47 -0.22, 0.37c -0.32, 0.23c
aRegression coefficient estimates and 95% CI were calculated based on differences between the incident vertebral and incident non-vertebral frac-
ture group versus the no fracture group (reference level: no incident fracture group) between pre and post HRQL measurements. The covariates 
included in the multiple regression analysis were group; baseline mini-OQLQ score; group by baseline mini-OQLQ score interaction; number of 
years between pre and post administration of the mini-OQLQ; age; baseline height; baseline weight; change in height (post-pre); prevalent vertebral 
and non-vertebral fracture status; number of prevalent vertebral and non-vertebral fractures; time spent exercising (hours/week); dietary calcium 
intake (g/day); baseline bone mineral density of the lumbar spine and femoral neck; medications such as bisphosphonates (etidronate or alendro-
nate), estrogen, or others (calcitonin, fluoride or raloxifene); and co-morbidities (including heart attack; stroke; breast, ovarian, cervical, uterine 
and colon cancer and multiple myeloma; diabetes, epilepsy, arthritis, and thyroid disease). b (n) = sample size. c indicates a non significant differ-
ences between groups (the non-vertebral fracture group (II) versus the no fracture group (III)).BMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/11
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fore, subclinical vertebral fractures may have developed in
all groups. The presence of subclinical vertebral fracture
has been documented to be associated with decreased ac-
tivity [8]. As a consequence, the actual differences in
HRQL scores may have been underestimated for those
with documented vertebral fractures versus those without.
In addition, the presence of non-vertebral fractures were
based on self-reports. This method of ascertainment may
lead to fracture misclassification [22].
In conclusion, this study demonstrates the detrimental
impact of clinically recognized incident vertebral and
non-vertebral fractures on quality of life in post-meno-
pausal women. Despite improvements in the medical
management of osteoporotic fractures, it is clear that frac-
tured patients continue to experience decreased quality of
life and that these deficits may often go unnoticed by cli-
nicians. Thus, the challenge for the future is to develop
treatment strategies to prevent and also reduce the pain as-
sociated with the fractures and to determine how patient
satisfaction is impacted when quality of life issues are con-
sidered during care.
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Appendix 1, The questionnaire includes 10 items.  For each questions 
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